Novo Nordisk Ltd

Support type: Corporate Pharma Supporters
Level: Gold

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 40,300 people in 75 countries, and markets its products in more than 180 countries.

Novo Nordisk shows responsibility to patients, employees, communities and investors. We will continue to build on the legacy left by the founders of Novo Nordisk and do whatever it takes to change diabetes. Novo Nordisk is committed to improving the lives of people living with diabetes. We take an innovative approach by addressing the challenges of diabetes as a whole, working with doctors, nurses and patient organisations to empower people with diabetes to self-manage their condition and improve their long-term health.

Information for HCPs

COVID-19 Information for Healthcare Professionals